Trading Ideas
Articles by admin
Trading Ideas
FDA approves emergency use of malaria pill for COVID-19 treatment
The Food and Drug Administration approved the anecdotally promising malaria drug for emergency use to treat hospitalized patients for Covid-19. …read more […]
Trading Ideas
Short term bond yields turn negative
Kathy Jones, Schwab Chief Fixed Income Strategist, joins Yahoo Finance’s Alexis Christoforous and Brian Sozzi to break down how the bond markets are weathering the coronavirus outbreak. …read more […]
Business News
Lockdown set to stymie Fiat attempt to restart some Italian production
A probable extension of Italy’s lockdown could frustrate an attempt by Fiat Chrysler to resume some vehicle production at three Italian plants next week, a union representative said on Monday.
Business News
Wall Street set to open higher as investors weigh stimulus against shutdown
Wall Street was set to open slightly higher on Monday as President Donald Trump followed last week’s massive fiscal stimulus by extending his stay-at-home guidelines, leaving investors guessing at their economic impact.
Trading Ideas
Tax filing deadline 2020: When are my state taxes due?
Uncle Sam is offering tax payers some relief by delaying the federal tax deadline, but don’t forget double check when your state taxes are due. …read more […]
Trading Ideas
Before You Buy Hillenbrand, Inc. (NYSE:HI), Consider Its Volatility
If you’re interested in Hillenbrand, Inc. (NYSE:HI), then you might want to consider its beta (a measure of share… …read more […]
Trading Ideas
J&J to start human testing of coronavirus vaccine by September
J&J also committed more than $1 billion of investment along with U.S. agency Biomedical Advanced Research and Development Authority (BARDA) to co-fund vaccine research, expanding a previous collaboration. A patient was dosed with Moderna Inc’s vaccine in an early-stage trial earlier this month, making it the front-runner in the race to develop a viable vaccine. J&J said in January it had begun working on a possible vaccine for the coronavirus, using the same technologies used to make its experimental Ebola vaccine. …read more […]
Business News
Facebook commits $100 million to support news media hurt by virus crisis
Facebook Inc on Monday pledged $100 million in financing and advertising spending to support news organizations, including local publishers in the United States, reeling from pressure due to the coronavirus pandemic.
Trading Ideas
Business News
Futures creep higher as U.S. heads for longer shutdown
U.S. stock markets inched higher on Monday as President Donald Trump followed last week’s passage of $2 trillion in stimulus by extending his stay-at-home guidelines until the end of April, leaving investors again guessing at the growing economic impact.
Trading Ideas
New services pop up to meet demand as telehealth market booms
The use of video conferencing services like Zoom and Skype has seen a boom as of late as more look for easier ways to work and communicate remotely. Linguistics tech company Jeenie is looking to offer that same solution for those needing interpretation services. …read more […]
Trading Ideas
EasyJet Founder Threatens to Oust Board Over Airbus Plane Order
(Bloomberg) — The coronavirus threat has handed EasyJet Plc’s founder, top shareholder and biggest critic a new weapon in his longstanding campaign to put the brakes on growth at the discount airline.Stelios Haji-Ioannou, who quit the board in protest over its expansion in 2010, has renewed his demand the U.K. carrier cancel an order for more than 100 Airbus SE narrow-body aircraft, arguing that the 4.5 billion-pound ($5.6 billion) cost threatens to drag the company down as the coronavirus pandemic cripples industry growth.The entrepreneur, who controls 34% of the stock, threatened to call one shareholder meeting a week to remove …read more […]
Business News
J&J to start human testing of coronavirus vaccine by September
Johnson & Johnson plans to start human testing of its experimental coronavirus vaccine by September and make it ready for emergency use in early 2021, the drugmaker said on Monday.
Trading Ideas
Mylan offers concessions to address EU concerns about Pfizer deal
Generic drugmaker Mylan NV has offered concessions to address European Union antitrust concerns about its bid for Pfizer’s off-patent branded drugs business Upjohn, a filing on the European Commission site showed on Monday. U.S. drugmaker Pfizer announced the deal in July as part of a strategy allowing it to focus on its more profitable newer medicines. The European Commission set an April 22 deadline for its decision after Mylan put in its offer on March 27. …read more […]